Safety Testing of Drug Metabolites
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 22, 2016
April 30, 2020
f87f3786-685f-4a28-963e-3499543cdd61
Related Documents
Nonclinical Testing of Orally Inhaled Nicotine-Containing Drug Products Guidance for Industry
Guidance DocumentOctober 28, 2020Center for Drug Evaluation and Research
Vulvovaginal Candidiasis: Developing Drugs for Treatment
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Osteoporosis: Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry: Guidance for Industry
Guidance DocumentAugust 15, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.